Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Kennedy-Wilson $200 million at-the-market offering and forward transaction
The stock is listed on the New York Stock Exchange
Hayward Holdings $348 million secondary offering
The stock is listed on the New York Stock Exchange
Lockheed Martin $2.3 billion senior notes offering
The investment-grade notes are due 2032, 2053 and 2062
RA Special Acquisition $230 million IPO
The SPAC IPO shares are listed on Euronext Amsterdam
SiTime at-the-market offering
The stock offering is SEC-registered
Livent investment in Nemaska Lithium
We are advising Livent on the transaction
Anthem $1.3 billion senior notes offering
The investment-grade notes are due 2032 and 2052
Deciphera Pharmaceuticals $172.5 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
SVB Financial Group $800 million notes offering
The investment-grade notes are due 2028 and 2033